학술논문

TROPHY-U-01, a phase II open-label study of sacituzumab govitecan in patients with metastatic urothelial carcinoma progressing after platinum-based chemotherapy and checkpoint inhibitors: updated safety and efficacy outcomes
Document Type
Article
Source
In Annals of Oncology April 2024 35(4):392-401
Subject
Urogenital tumors
Language
ISSN
0923-7534